Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Ho

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Cancer Medicine|November 17, 2021
Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real worldAria Shokoohi, Zamzam Al-Hashami, Sara Moore, et al.
Cureus|November 17, 2018
Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc TherapyJoshua Giambattista, Nevin McVicar, Sarah Hamilton, et al.
Cureus|April 8, 2020
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based ExperienceAria Shokoohi, Eric Berthelet, Sabrina Gill, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2013
A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced diseaseCaroline Mariano, Ian Bosdet, Aly Karsan, et al.
Investigational New Drugs|April 19, 2007
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I studyAngela M Davies, Cheryl Ho, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2020
Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancerSarah Nicole Hamilton, Eric Tran, Cheryl Ho, et al.
Cancers|January 25, 2025
Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT DatasetsMohammad R Salmanpour, Arman Gorji, Amin Mousavi, et al.
Studies in Health Technology and Informatics|February 8, 2013
The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration SystemJonn Wu, Cheryl Ho, Janessa Laskin, et al.
Head & Neck|January 1, 2019
Predictors of thyroxine replacement following hemithyroidectomy in a south east Asian cohortPeng Ng, Cheryl Ho, Wee Boon Tan, et al.
Clinical Lung Cancer|July 17, 2017
Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of OutcomesShaan Dudani, Xiaofu Zhu, Daniel W Yokom, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Cancer Medicine|November 17, 2021
Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real worldAria Shokoohi, Zamzam Al-Hashami, Sara Moore, et al.
Cureus|November 17, 2018
Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc TherapyJoshua Giambattista, Nevin McVicar, Sarah Hamilton, et al.
Cureus|April 8, 2020
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based ExperienceAria Shokoohi, Eric Berthelet, Sabrina Gill, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2013
A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced diseaseCaroline Mariano, Ian Bosdet, Aly Karsan, et al.
Investigational New Drugs|April 19, 2007
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I studyAngela M Davies, Cheryl Ho, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2020
Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancerSarah Nicole Hamilton, Eric Tran, Cheryl Ho, et al.
Cancers|January 25, 2025
Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT DatasetsMohammad R Salmanpour, Arman Gorji, Amin Mousavi, et al.
Studies in Health Technology and Informatics|February 8, 2013
The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration SystemJonn Wu, Cheryl Ho, Janessa Laskin, et al.
Head & Neck|January 1, 2019
Predictors of thyroxine replacement following hemithyroidectomy in a south east Asian cohortPeng Ng, Cheryl Ho, Wee Boon Tan, et al.
Clinical Lung Cancer|July 17, 2017
Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of OutcomesShaan Dudani, Xiaofu Zhu, Daniel W Yokom, et al.
Pageof 12